http://orcid.org/0000-0002-5607-6683
About the Authors
- Shovik Bandyopadhyay
-
Contributed equally to this work with: Shovik Bandyopadhyay, Junjie Li
Affiliation Department of Biological Sciences, Purdue University, West Lafayette, Indiana, United States of America
- Junjie Li
-
Contributed equally to this work with: Shovik Bandyopadhyay, Junjie Li
Affiliation Weldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana, United States of America
- Elie Traer
-
Affiliation Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, United States of America
- Jeffrey W. Tyner
-
Affiliations Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, United States of America, Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon, United States of America
- Amy Zhou
-
Affiliation Division of Hematology, Washington University School of Medicine, St. Louis, Missouri, United States of America
- Stephen T. Oh
-
* E-mail: jcheng@purdue.edu (JXC); stoh@dom.wustl.edu (STO)
Affiliation Division of Hematology, Washington University School of Medicine, St. Louis, Missouri, United States of America
- Ji-Xin Cheng
-
* E-mail: jcheng@purdue.edu (JXC); stoh@dom.wustl.edu (STO)
Affiliations Weldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana, United States of America, Center for Cancer Research, Purdue University, West Lafayette, Indiana, United States of America
Competing Interests
J.L. and J-X.C. are co-founders of Resarci Therapeutics LLC. This does not alter our adherence to PLOS ONE policies on sharing data and materials. Other authors declare no competing financial interests.
Author Contributions
Conceptualization: SB JL STO JXC. Data curation: SB JL. Formal analysis: SB JL. Funding acquisition: STO JXC. Investigation: SB JL. Methodology: SB JL ET JWT STO JXC. Project administration: SB JL STO JXC. Resources: ET JWT AZ STO JXC. Supervision: STO JXC. Validation: SB JL. Visualization: SB JL STO JXC. Writing – original draft: SB JL. Writing – review & editing: SB JL ET JWT STO JXC.